PATENT CLAIM ANALYSIS

Application Number: 15883218
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "145100"]

Abstract:
The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.

Claim (Index 1):
A method for treating headache in an individual, comprising: administering to the individual an effective amount of a humanized monoclonal anti-Calcitonin Gene-Related Peptide (CGRP) antagonist antibody and at least one additional agent,\n wherein the antagonist antibody comprises: two human IgG heavy chains, each heavy chain comprising three complementarity determining regions (CDRs) and four framework regions, wherein portions of the two heavy chains together form an Fc region; and two light chains, each light chain comprising three CDRs and four framework regions; wherein the CDRs impart to the antibody specific binding to a CGRP consisting of amino acid residues 1 to 37 of SEQ ID NO:15 or SEQ ID NO: 43.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 86.0
- Lexical Diversity: 1.24444
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15588432', '15588461', '14719015', '13179846', '15044552']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8291250486307423
- 35 USC 102 Novelty (BERT): 0.6704221927044455
- Combined Prediction Score: 0.8132547630381126
- Mean Citation Score: 697.1334599999999
- Max Citation Score: 710.2112
- Similarity Product: 621.4422080801011

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test